National Institute of General Medical Sciences; Notice of Closed Meetings, 34586 [E9-16840]
Download as PDF
<![CDATA[
34586
Federal Register / Vol. 74, No. 135 / Thursday, July 16, 2009 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control; 93.701, ARRA Related
Biomedical Research and Research Support
Awards, National Institutes of Health, HHS)
Dated: July 9, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–16890 Filed 7–15–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Impact of Tic
Disorders, Including Tourette
Syndrome, in Youth, on Individuals,
Families, and Communities, Funding
Opportunity Announcement (FOA)
DD09–004, Initial Review
erowe on DSK5CLS3C1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 10:30 a.m.–12:30 p.m., July
31, 2009 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of ‘‘Impact of Tic Disorders,
Including Tourette Syndrome, in Youth, on
Individuals, Families, and Communities,
FOA DD09–004.’’
Contact Person for More Information:
Michael Dalmat, Scientific Review
Administrator, CDC, 1600 Clifton Road, NE.,
Mailstop K92, Atlanta, GA 30333, Telephone
(770) 488–6423.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
VerDate Nov<24>2008
15:08 Jul 15, 2009
Jkt 217001
Dated: July 9, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–16921 Filed 7–15–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences, Special Emphasis
Panel Expanding the Chemical Space for
Carbohydrates.
Date: July 23–24, 2009 Time: 8:30 a.m. to
5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Room 3AN18, 45 Center
Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: C. Craig Hyde, PhD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health,
Building 45, Room 3AN18, Bethesda, MD
20892, 301–435–3825. ch2v@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
General Medical Sciences, Special Emphasis
Panel ARRA Funds—Leukocyte Gene
Expression in Healthy Humans.
Date: August 3, 2009.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Room 3AN18, 45 Center
Drive, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Brian R. Pike, PhD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN18, Bethesda, MD
20892, 301–594–3907, pikbr@mail.nih.gov.
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Name of Committee: National Institute of
General Medical Sciences, Special Emphasis
Panel ARRA Funds—Pharmacogenomics &
Electronic Health Records.
Date: August 6, 2009.
Time: 4 p.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natther Building, Room 3AN18, 45 Center
Drive, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Brian R. Pike, PhD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN18, Bethesda, MD
20892, 301–594–3907, pikbr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.701, ARRA
Related Biomedical Research and Research
Support Awards, National Institutes of
Health, HHS)
Dated: July 8, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–16840 Filed 7–15–09; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Internal Agency Docket No. FEMA–1843–
DR; Docket ID FEMA–2008–0018]
Alaska; Amendment No. 2 to Notice of
a Major Disaster Declaration
AGENCY: Federal Emergency
Management Agency, DHS.
ACTION: Notice.
SUMMARY: This notice amends the notice
of a major disaster declaration for the
State of Alaska (FEMA–1843–DR), dated
June 11, 2009, and related
determinations.
DATES:
Effective Date: July 1, 2009.
FOR FURTHER INFORMATION CONTACT:
Peggy Miller, Disaster Assistance
Directorate, Federal Emergency
Management Agency, 500 C Street, SW.,
Washington, DC 20472, (202) 646–3886.
SUPPLEMENTARY INFORMATION: The notice
of a major disaster declaration for the
State of Alaska is hereby amended to
include the following areas among those
areas determined to have been adversely
affected by the event declared a major
E:\FR\FM\16JYN1.SGM
16JYN1
]]>Agencies
[Federal Register Volume 74, Number 135 (Thursday, July 16, 2009)]
[Notices]
[Page 34586]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-16840]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of General Medical Sciences; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of General Medical
Sciences, Special Emphasis Panel Expanding the Chemical Space for
Carbohydrates.
Date: July 23-24, 2009 Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building, Room
3AN18, 45 Center Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: C. Craig Hyde, PhD, Scientific Review Officer,
Office of Scientific Review, National Institute of General Medical
Sciences, National Institutes of Health, Building 45, Room 3AN18,
Bethesda, MD 20892, 301-435-3825. ch2v@nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of General Medical
Sciences, Special Emphasis Panel ARRA Funds--Leukocyte Gene
Expression in Healthy Humans.
Date: August 3, 2009.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building, Room
3AN18, 45 Center Drive, Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Brian R. Pike, PhD, Scientific Review Officer,
Office of Scientific Review, National Institute of General Medical
Sciences, National Institutes of Health, 45 Center Drive, Room
3AN18, Bethesda, MD 20892, 301-594-3907, pikbr@mail.nih.gov.
Name of Committee: National Institute of General Medical
Sciences, Special Emphasis Panel ARRA Funds--Pharmacogenomics &
Electronic Health Records.
Date: August 6, 2009.
Time: 4 p.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natther Building, Room
3AN18, 45 Center Drive, Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Brian R. Pike, PhD, Scientific Review Officer,
Office of Scientific Review, National Institute of General Medical
Sciences, National Institutes of Health, 45 Center Drive, Room
3AN18, Bethesda, MD 20892, 301-594-3907, pikbr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.375,
Minority Biomedical Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology, Physiology, and
Biological Chemistry Research; 93.862, Genetics and Developmental
Biology Research; 93.88, Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.701, ARRA Related Biomedical
Research and Research Support Awards, National Institutes of Health,
HHS)
Dated: July 8, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-16840 Filed 7-15-09; 8:45 am]
BILLING CODE 4140-01-M
